IRCT20220902055858N1
Recruiting
Phase 3
A comparative analysis of effects of empagliflozin whit metformin on cardiometabolic factors and blood glucose of prediabetic patients
Shahre-kord University of Medical Sciences0 sites90 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Condition 1: Impaired fasting glucose. Condition 2: Impaired glucose tolerance.
- Sponsor
- Shahre-kord University of Medical Sciences
- Enrollment
- 90
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Prediabetic Patient
- •Age 17 to 65 years
- •Not receiving blood sugar\-lowering drugs
Exclusion Criteria
- •Known case of Diabetes
- •A history of urinary tract infection
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
Phase 3
Comparison of therapeutic effect of Empagliflozin (Gloripa) and Sitagliptin (Ziptin) on type 2 Diabetic patientsIRCT20200810048355N1Vice Chancellor for Research, Islamic Aazad University, Najafabad branch128
Recruiting
Phase 2
The cardiac effect of pioglitazone and empagliflozin among diabetic patients with NAFLDCondition 1: Nonalcoholic fatty liver disease. Condition 2: Type 2 Diabetes. Condition 3: Cardiomyopathy.Nonalcoholic steatohepatitis (NASH)Type 2 diabetesCardiomyopathyK75.81IRCT20190122042450N5Iran University of Medical Sciences70
Not Yet Recruiting
Phase 3
Evaluation of the effect of Empagliflozin on the severity of heart failure symptoms and echocardiography parameters in patients with congenital heart diseases with left-to-right shuntIRCT20120520009801N11Mashhad University of Medical Sciences44
Completed
Phase 3
Effect of Empagliflozin in prevention of kidney stone parametersIRCT20211203053261N2Hamedan University of Medical Sciences138
Recruiting
Phase 4
The effect of empagliflozin in patients with idiopathic edemaIdiopathic edema.Edema, unspecifiedR60.9IRCT20230314057712N1Ahvaz University of Medical Sciences70